noon glp-1 medications are transforming how we approach weight loss. This session examines potential side effects, emerging questions about long-term use, and how these drugs affect the body during and after treatment. The GLP-1 medications are transforming how

Novo Nordisk, the manufacturer of Ozempic, announced a plan to reduce its global workforce by approximately 9,000 positions today.

Steadier, more sustainable weight management when paired with diet and lifestyle changes

Freeze your smoothie packs and grain bowls

This combination leverages amylin's ability to promote feelings of fullness and slow stomach emptying

Propensity score fine stratification weighted Cox proportional hazards models were fitted to estimate hazard ratios and 95% confidence intervals (CIs) to estimate the average treatment effect among the treated patients

Your workforce likely has a growing interest (or curiosity) in GLP-1 medications